A Mother's Battle With Advanced Colon Cancer

fall of 2003, Bridget Beranek, a 44-year-old wife andFortunately for Bridget, a new treatment for metastatic
mother of two young girls, was gearing up for a busycolorectal cancer had just been approved by the FDA,
holiday season filled with family functions, parties andonly weeks before her diagnosis. Her oncologist
shopping. So when she began to lose her appetite anddecided to treat her with a combination of traditional
energy, Bridget initially chalked it up to holiday stress.chemotherapy and a targeted therapy called
When the New Year came and went, but Bridget'sAvastin® (bevacizumab). Though she occasionally
symptoms were still present, she knew it was morehas side effects such as fatigue, Bridget's cancer has
than stress. After several visits to her primary careresponded to the treatment and she is doing well. She
physician, Bridget saw an internist, and underwent ais thankful to be able to spend time with her husband
colonoscopy. In March 2004, she was diagnosed withand daughters, and to practice her favorite hobby,
stage IV colorectal cancer that had spread to her liver.photography.
"I know it sounds cliché, but I couldn't believe thisTypically, metastatic colorectal cancer patients
was happening to me," said Bridget. "Scheduling aundergo surgery followed by chemotherapy. Today's
colonoscopy was not a priority for me because I wastargeted therapies, which are designed to attack
under 50 and lived a healthy lifestyle. I ate right, didn'tcancer cells in a more specific way than
drink or smoke, and went regularly for a mammogram.chemotherapy, provide an additional tool for doctors to
One thing I learned from this experience is that colonuse in treating this disease. Avastin, for example, is an
cancer is a disease more people, especially women,angiogenesis inhibitor, which means it interferes with
need to be better informed about."the blood vessels that feed cancer tumors, to help
The American Cancer Society reports that colorectalprevent tumors from growing and spreading to other
cancer, commonly referred to as colon cancer, is theparts of the body. Avastin is approved for use in
second-leading cause of cancer-related death in thecombination with intravenous 5-fluorouracil-based
United States, second only to lung cancer. It is also thechemotherapy for first-line treatment of patients with
third most common cancer diagnosed in both men andmetastatic colorectal cancer.
women.It is important to keep in mind that Avastin has been
Risk factors for colon cancer include a family orassociated with side effects in colorectal cancer.
personal history of the disease, intestinal polyps orSerious side effects occur rarely, but can include
chronic inflammatory bowel disease, obesity, a high-fatgastrointestinal perforation and slow or incomplete
diet, and being age 50 or older. Symptoms may includewound healing and blood clot complications. Other
changes in bowel habits, abdominal discomfort,more common side effects seen in clinical trials include
vomiting, fatigue, blood in the stool or unexplainednosebleeds, high blood pressure, proteinuria (too much
weight loss, though many people are diagnosedprotein in the urine, which may be a sign of kidney
without any symptoms.damage), weakness, pain, diarrhea, and a reduced
The Centers for Disease Control and Preventionwhite blood cell count.
(CDC) recommends men and women over age 50Because everyone is different, it is not possible to
who have an average risk for colon cancer receivepredict what side effects an individual may experience.
screening. Higher-risk patients, such as those with aIf you have questions about side effects or treatment
family history of the disease, should talk with theirwith Avastin, talk to your doctor or another member of
physicians about when they should begin screening.the health-care team.